The Childhood Cancer Blog

The Childhood Cancer Blog

Welcome to The Childhood Cancer Blog
from Alex's Lemonade Stand Foundation!

  • Philip, who diagnosed at 3 years old with neuroblastoma, looks on as his mom Wendy meets Alex Scott's mom, Liz, for the first time. Both mothers shared the bond of having children who faced ALK-driven neuroblastoma.
    Philip, who diagnosed at 3 years old with neuroblastoma, looks on as his mom Wendy meets Alex Scott's mom, Liz, for the first time. Both mothers shared the bond of having children who faced ALK-driven neuroblastoma.
  • Arden is now 5 years old. Like Philip, she was diagnosed with high-risk neuroblastoma. This year, the results of the trial that saved her life were published in Nature Medicine.
    Arden is now 5 years old. Like Philip, she was diagnosed with high-risk neuroblastoma. This year, the results of the trial that saved her life were published in Nature Medicine.
  • ALSF funded-researcher Dr. Yael Mossé (pictured above) is the lead author on a new paper published in Nature Medicine. The paper shares the results of Dr. Mossé’s clinical trial for lorlatinib, a targeted therapy that showed success treating children with neuroblastoma tumors harboring the ALK mutation.
    ALSF funded-researcher Dr. Yael Mossé (pictured above) is the lead author on a new paper published in Nature Medicine. The paper shares the results of Dr. Mossé’s clinical trial for lorlatinib, a targeted therapy that showed success treating children with neuroblastoma tumors harboring the ALK mutation.

In 2023, Alex’s Lemonade Stand Foundation saw all the hard work, dedication and research pay off in a big way for children with cancer. From high-impact publications to breakthroughs to funding new projects, ALSF continued its commitment to finding safer treatments and cures for all childhood with cancer.

The best part: It is all fueled by lemonade. 

Here are the top childhood cancer research stories from 2023:

1.    Over 100 awarded grants—114 to be exact--funded in 2023

From extending grant funding for researchers close to breakthrough to funding student... Read More

  • Dr. Roberts
    Dr. Roberts (pictured above) is part of a dream team of childhood cancer researchers from all specialties and all over the world funded by an Alex’s Lemonade Stand Foundation (ALSF) Crazy 8 Initiative Grant. The Crazy 8 Initiative with support from partner Northwestern Mutual has provided $26 million in grant funding to six projects led by researchers at 21 institutions all over the world.
  • The crazy 8 summit members
    In November, the Crazy 8 teams gathered for a meeting in Philadelphia, PA. Teams are made up of specialists from all realms working together within their own projects and also collaborating with each other across institutions and oceans.

Dr. Ryan Roberts, an oncologist and researcher from Nationwide Children’s Hospital, sees the havoc childhood cancer reigns on children and their families every day. 

“It causes long, painful, and sometimes futile battles for kids. Some of my patients spend the entirety of middle school and high school on chemotherapy, ultimately unsuccessfully,” said Dr. Roberts. 

Dr. Roberts specializes in the treatment of osteosarcoma, the most common, but still rare, pediatric bone cancer that happens primarily in adolescents. While surgical techniques have improved over the past several... Read More

To kick off 2023, Alex’s Lemonade Stand Foundation (ALSF) has funded six new childhood cancer projects for both early career and established researchers.  

ALSF is committed to changing the future of childhood cancer research by funding scientists and projects that will bring better treatments and cures to children with cancer. Attracting and retaining the best and brightest early career scientists is critical, as the funding at this stage will encourage and steer promising researchers toward long-term careers in pediatric oncology investigation. 

That’s why ALSF designed... Read More

Pages